A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...
Researchers at UVA Health have found that a class of HIV drugs called nucleotide reverse transcriptase inhibitors (NRTIs) may significantly reduce the risk of developing Alzheimer’s disease. Their ...
Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...
Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...
UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are substantially ...
Four men in King County have been diagnosed with a strain of HIV that is extremely hard to treat, and health officials are concerned it could spread further. At least two types of HIV drugs don’t work ...
Although much has been published on medication prescribing errors, little information is available regarding the frequency of medication prescribing errors with antiretroviral agents in the ...
The researchers note that patients taking other types of HIV medications did not show the same reduction in Alzheimer's risk as those on NRTIs. Based on that, they say that NRTIs warrant clinical ...
Four men in King County have been diagnosed with a strain of HIV that is extremely hard to treat, and health officials are concerned it could spread further. At least two types of HIV drugs don’t work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results